IVD Antibody Development Services for BCR-ABL Marker - Creative Biolabs
Hsp90 Inhibitors for the Treatment of Chronic Myeloid Leukemia
Effect of HSP90AB1 and CC domain interaction on Bcr-Abl protein cytoplasm localization and function in chronic myeloid leukemia cells | Cell Communication and Signaling | Full Text
Potential Role of Notch Signalling in CD34+ Chronic Myeloid Leukaemia Cells: Cross-Talk between Notch and BCR-ABL | PLOS ONE
Modern Therapy of Chronic Myeloid Leukemia | IntechOpen
BCR-ABL1-independent PI3Kinase activation causing imatinib-resistance | Journal of Hematology & Oncology | Full Text
Differential signaling networks of Bcr–Abl p210 and p190 kinases in leukemia cells defined by functional proteomics | Leukemia
Integrative phosphoproteome and interactome analysis of the role of Ubash3b in BCR-ABL signaling | Leukemia
BCR-ABL fusion protein
PDF] Regulatory Molecules and Corresponding Processes of BCR-ABL Protein Degradation | Semantic Scholar
NEJM -- Chronic Myeloid Leukemia -- Advances in Biology and New Approaches to Treatment -- Figure 3
Bcr-Abl tyrosine-kinase inhibitor - Wikipedia
IJMS | Free Full-Text | Blockade of Y177 and Nuclear Translocation of Bcr- Abl Inhibits Proliferation and Promotes Apoptosis in Chronic Myeloid Leukemia Cells